<SEC-DOCUMENT>0001140361-23-012880.txt : 20230322
<SEC-HEADER>0001140361-23-012880.hdr.sgml : 20230322
<ACCEPTANCE-DATETIME>20230321204138
ACCESSION NUMBER:		0001140361-23-012880
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230322
DATE AS OF CHANGE:		20230321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			D-Wave Quantum Inc.
		CENTRAL INDEX KEY:			0001907982
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267124
		FILM NUMBER:		23751078

	BUSINESS ADDRESS:	
		STREET 1:		3033 BETA AVENUE
		CITY:			BURNABY
		STATE:			A1
		ZIP:			V5G4M9
		BUSINESS PHONE:		(604) 630-1428

	MAIL ADDRESS:	
		STREET 1:		3033 BETA AVENUE
		CITY:			BURNABY
		STATE:			A1
		ZIP:			V5G4M9
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>brhc10050103_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, LLC
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Filed Pursuant to Rule 424(b)(3)</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-267124</div>
    <div>&#160;</div>
    <div style="font-weight: bold;">PROSPECTUS SUPPLEMENT NO. 9</div>
    <div style="font-weight: bold;">(to Prospectus dated October 26, 2022)</div>
    <div> <br>
    </div>
    <div style="text-align: center;"><img src="image00001.jpg"></div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">D-WAVE QUANTUM INC.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">COMMON SHARES</div>
    <div style="text-align: center; font-weight: bold;">WARRANTS TO PURCHASE COMMON SHARES</div>
    <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING EXCHANGEABLE SHARES</div>
    <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING D-WAVE OPTIONS</div>
    <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING D-WAVE WARRANTS</div>
    <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING WARRANTS</div>
    <div> <br>
    </div>
    <div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div><br>
      </div>
    </div>
    <div>This prospectus supplement updates, amends and supplements the prospectus contained in our Registration Statement on Form S-1, effective as of October 26, 2022 (as supplemented or amended from time to time, the &#8220;Prospectus&#8221;) (Registration No.
      333-267124).</div>
    <div>&#160;</div>
    <div>This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on
      March 21, 2023 (the &#8220;Form 8-K&#8221;). Accordingly, we have attached the Form 8-K to this prospectus supplement.</div>
    <div>&#160;</div>
    <div>This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto,
      except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.</div>
    <div>&#160;</div>
    <div>Our shares of common stock, par value $0.0001 (&#8220;Common Shares&#8221;), and warrants to purchase Common Shares (&#8220;Warrants&#8221;), each whole Warrant exercisable for 1.4541326 Common Shares at an exercise price of $11.50, are listed on the New York Stock
      Exchange (the &#8220;NYSE&#8221;) under the symbols &#8220;QBTS&#8221; and &#8220;QBTS.WT,&#8221; respectively. On March 21, 2023, the last reported sales prices for the Common Shares and Warrants on the NYSE were $0.55 and $0.0931, respectively.</div>
    <div> <br>
    </div>
    <div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <div>&#160;</div>
    <div style="font-weight: bold;">Investing in our securities involves a high degree of risk. <font style="color: rgb(0, 0, 0);">See &#8220;<u>Risk Factors</u>&#8221; beginning </font>on page 50 of the Prospectus for a discussion of applicable information that
      should be considered in connection with an investment in our securities.</div>
    <div>&#160;</div>
    <div style="font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement is truthful or complete.
      Any representation to the contrary is a criminal offense.</div>
    <div> <br>
    </div>
    <div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">The date of this prospectus supplement is March 21, 2023.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div>
        <div>
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
          <div>
            <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
            <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
            <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
            <div style="text-align: center; font-weight: bold;"> <br>
            </div>
            <div style="text-align: center;">
              <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 35%; color: #000000;"></div>
            <div>&#160;</div>
            <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 8-K</div>
            <div style="text-align: center; font-weight: bold;"><font style="color: rgb(0, 0, 0);"> <br>
              </font></div>
            <div style="text-align: center;">
              <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 35%; color: #000000;"></div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">CURRENT REPORT</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE</div>
            <div style="text-align: center; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">Date of Report (Date of earliest event reported): March 16, 2023</div>
            <div style="text-align: center; font-weight: bold;"> <br>
            </div>
            <div style="text-align: center;">
              <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 35%; color: #000000;"></div>
            <div>&#160;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">D-Wave Quantum Inc.<br>
            </div>
            <div style="text-align: center; font-weight: bold;">(Exact Name of Registrant as Specified in Its Charter)</div>
            <div style="text-align: center; font-weight: bold;"> <br>
            </div>
            <div style="text-align: center;">
              <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 35%; color: #000000;"></div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" id="zb62bd67189b245d0bdf5c1e77391aa09" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 32%; vertical-align: top;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Delaware<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: top;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">001-41468<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: top;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">84-1068854<br>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(State or other jurisdiction of</font><font style="font-size: 10pt;">&#160;</font></div>
                    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">incorporation or organization)</font></font></div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(Commission</font><font style="font-size: 10pt;">&#160;</font></div>
                    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">File Number)</font></font></div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">(I.R.S. Employer</font><font style="font-size: 10pt;">&#160;</font></div>
                    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Identification No.)</font></font></div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">3033 Beta Avenue<br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Burnaby, British Columbia</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Canada</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">V5G 4M9<br>
            </div>
            <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">(604) 630-1428</div>
            <div style="text-align: center; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">N/A</div>
            <div style="text-align: center; font-weight: bold;">(Former name or former address, if changed since last report)</div>
            <div style="text-align: center; font-weight: bold;"> <br>
            </div>
            <div style="text-align: center;">
              <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 35%; color: #000000;"></div>
            <div><br>
            </div>
            <div>&#160;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
              provisions:</div>
            <div>&#160; <br>
            </div>
            <table cellspacing="0" cellpadding="0" id="zfd38ad5b0a0148aaa3e578b7eeef20fa" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(51, 51, 51);">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" id="z460bf97e2578417ca20614b9175c190e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(51, 51, 51);">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" id="z244054854c824883b02edd3c0e460377" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(51, 51, 51);">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" id="zc12c8affe5534b4aa725093d2e562cd0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(51, 51, 51);">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                  </td>
                </tr>

            </table>
            <div>&#160; <br>
            </div>
            <div>Securities registered pursuant to Section 12(b) of the Act:</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" id="zc8616867f7164e558cfa161a07e735b6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of each class</div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Trading Symbol(s)</div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name of each exchange on which registered</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: rgb(0, 0, 0);">Common stock, par value $0.0001 per share<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: rgb(0, 0, 0);">QBTS<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: rgb(0, 0, 0);">New York Stock Exchange<br>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">Warrants, each whole warrant exercisable for 1.4541326 shares of common stock at an exercise price of $11.50<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">QBTS.WT<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">New York Stock Exchange<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
              12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" id="zf4de0f46216d4efd8b3ef22a09e10b33" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 95.31%; vertical-align: bottom;">
                    <div style="text-align: right; color: rgb(0, 0, 0);">Emerging growth company</div>
                  </td>
                  <td style="width: 1.17%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 3.51%; vertical-align: bottom;">
                    <div style="color: rgb(51, 51, 51);">&#9746;<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" id="z38fa72cfa8c645c280403c4d5a64559e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 95.31%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
                      standards provided pursuant to Section 13(a) of the Exchange Act.</div>
                  </td>
                  <td style="width: 1.17%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 3.51%; vertical-align: bottom;">
                    <div style="color: rgb(51, 51, 51);">&#9744;<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div>
              <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <table cellspacing="0" cellpadding="0" id="z5a8cd8689d4248e08c98e763b19f6d5f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 63pt; vertical-align: top; font-weight: bold;">Item 3.01.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div><font style="color: rgb(0, 0, 0);">On </font>March
                16, 2023<font style="color: rgb(0, 0, 0);">, D-Wave Quantum Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) was notified by the New York Stock Exchange (the &#8220;NYSE&#8221;) that it is not in compliance with Section 802.01C of the NYSE Listed Company
                  Manual because the average closing price of the Company&#8217;s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company&#8217;scommon stock from the NYSE.</font></div>
            <div>&#160;</div>
            <div><font style="color: rgb(0, 0, 0);">On </font>March
                20, 2023<font style="color: rgb(0, 0, 0);">, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The Company can regain compliance at any
                  time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period the Company has a closing share price of at least $1.00 and an average closing share price of at
                  least $1.00 over the 30 trading-day period ending on the last trading day of that month.</font></div>
            <div>&#160;</div>
            <div><font style="color: rgb(0, 0, 0);">Under the NYSE&#8217;s rules, if the Company determines that, if necessary, it will
                cure the stock price deficiency by taking an action that will require stockholder approval, it must so inform the NYSE in the above referenced notification and the price condition will be deemed cured if the price promptly exceeds $1.00 per
                share, and the price remains above that level for at least the following 30 trading days.</font>&#160;<font style="color: rgb(0, 0, 0);">The Company intends to consider available alternatives, including but not limited to a reverse stock split, that are subject to shareholder approval.</font></div>
            <div>&#160;</div>
            <div style="color: rgb(0, 0, 0);">The Company&#8217;s common stock will continue to be listed and trade on the NYSE during this period, subject to the Company&#8217;s compliance with other
              NYSE continued listing standards.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z5e86d2521536432ca4372741f268a5bf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 7.01.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">Regulation FD Disclosure.</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div><font style="color: rgb(0, 0, 0);">As required by Section 802.01C of the NYSE Listed Company Manual, the Company
                issued a press release on </font>March 21, 2023<font style="color: rgb(0, 0, 0);">, announcing that it had received the notice of noncompliance with the NYSE&#8217;s continued
                  listing standard. A copy of the press release is furnished herewith as Exhibit 99.1.</font></div>
            <div>&#160;</div>
            <div style="color: rgb(0, 0, 0);">The information in this Item 7.01, including the information contained in Exhibit 99.1 of this Current Report on Form 8-K, is being furnished
              herewith and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by
              reference in any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, regardless of any general incorporation language in such filing.</div>
            <div>&#160;</div>
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Forward Looking Statements</div>
            <div>&#160;</div>
            <div style="color: rgb(0, 0, 0);">This Current Report on Form 8-K includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section 21E
              of the Exchange Act. These statements express a belief, expectation or intention and are generally accompanied by words that convey projected future events or outcomes. For example, statements regarding the Company&#8217;s intention to consider
              alternatives to cure the NYSE continued listing requirement deficiency are forward-looking statements. We have based these forward-looking statements on our current expectations and assumptions and analyses made by us in light of our
              experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate under the circumstances. However, whether actual results and developments will
              conform with our expectations and predictions is subject to a number of risks and uncertainties, many of which are beyond our control, including the Company&#8217;s ability to regain compliance with the continued listing standards of the NYSE
              within the applicable cure period, the Company&#8217;s ability to continue to comply with applicable listing standards of the NYSE and the other important factors set forth under the caption &#8220;Risk Factors&#8221; in the Company&#8217;s Registration Statement on
              Form S-1 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 13, 2023, and the Company&#8217;s other reports filed with the SEC. All of the forward-looking statements made in this Current Report on Form 8-K are qualified by
              these cautionary statements. The actual results or developments anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on our Company or our business or operations. Such
              statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. You should not place undue reliance on forward-looking statements, which
              speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable
              securities laws.</div>
            <div style="color: rgb(0, 0, 0);"> <br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <table cellspacing="0" cellpadding="0" id="z5a3272dec4474cda91c10edc9b6fe4c7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 63pt; vertical-align: top; font-weight: bold;">Item 9.01.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z5da14ba76cd84bc798c88bc0d13cbe8c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 18pt; vertical-align: top;">(d)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>Exhibits</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" id="z0a0d9ac5e8064cf88ff4567d1c4a8d4f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 20%; vertical-align: top;">
                    <div style="font-weight: bold;"><u>Exhibit Number</u></div>
                  </td>
                  <td style="width: 80%; vertical-align: top;">
                    <div style="font-weight: bold;"><u>Description</u></div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" style="width: 80%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 20%; vertical-align: top;">
                    <div>99.1</div>
                  </td>
                  <td style="width: 80%; vertical-align: top;">
                    <div>Press Release of D-Wave Quantum Inc., dated March 21, 2023</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 20%; vertical-align: top;" rowspan="1">&#160;</td>
                  <td style="width: 80%; vertical-align: top;" rowspan="1">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 20%; vertical-align: top;">
                    <div>104</div>
                  </td>
                  <td style="width: 80%; vertical-align: top;">
                    <div>Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
            <div>&#160;</div>
            <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
              hereunto duly authorized.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" id="z7599481fb47d40cea58f6f8a6fd4f96c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="vertical-align: bottom;" colspan="2">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">D-Wave Quantum Inc.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 5%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 44.51%; vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">
                    <div><font style="color: rgb(0, 0, 0);">Dated: </font>March 21, 2023</div>
                  </td>
                  <td style="width: 5%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">By:</div>
                  </td>
                  <td style="width: 44.51%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="color: rgb(0, 0, 0);">/s/ Alan Baratz</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 5%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Name:</div>
                  </td>
                  <td style="width: 44.51%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Alan Baratz</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 5%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Title:</div>
                  </td>
                  <td style="width: 44.51%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">President &amp; Chief Executive Officer</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div><br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div> </div>
          </div>
        </div>

        <div>
          <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
          <div>
            <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Exhibit 99.1</div>
            <div><br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">D-Wave Receives Notice of Non-Compliance with NYSE Trading Share Price Listing Rule</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">Intends to cure the deficiency and return to compliance with NYSE standard</div>
            <div><br>
            </div>
            <div style="color: #000000;"><font style="font-weight: bold;">BURNABY, B.C. &amp; PALO ALTO, Calif. &#8211; March 21, 2023 &#8211; </font><u>D-Wave Quantum Inc.</u> (NYSE: QBTS) (the "Company"), a leader in quantum computing systems, software, and service, and the only commercial
                provider building both annealing and gate-model quantum computers,&#160;today announced that it received notice from the New York Stock Exchange (the &#8220;NYSE&#8221;) on March 16, 2023 that it is not
                in compliance with Section 802.01C of the NYSE Listed Company Manual because, as of March 15, 2023, the average closing price of the Company&#8217;s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not
                result in the immediate delisting of the Company&#8217;s common stock from the NYSE.</div>
            <div><br>
            </div>
            <div style="color: rgb(0, 0, 0);">On March 20, 2023, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE
              continued listing standard. The Company can regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period the Company has a closing share
              price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.</div>
            <div><br>
            </div>
            <div style="color: rgb(0, 0, 0);">Under the NYSE&#8217;s rules, if the Company determines that, if necessary, it will cure the stock price deficiency by taking an action that will
              require stockholder approval, it must so inform the NYSE in the above referenced notification and the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above that level for at least the
              following 30 trading days. The Company intends to consider available alternatives, including but not limited to a reverse stock split, that are subject to shareholder approval.</div>
            <div><br>
            </div>
            <div style="color: rgb(0, 0, 0);">The Company&#8217;s common stock will continue to be listed and trade on the NYSE during this period, subject to the Company&#8217;s compliance with other
              NYSE continued listing standards.</div>
            <div><br>
            </div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">About D-Wave Quantum Inc.</div>
            <div style="color: rgb(0, 0, 0);">D-Wave is a leader in the development and delivery of quantum computing systems, software, and services, and is the world&#8217;s first commercial
              supplier of quantum computers&#8212;and the only company building both annealing quantum computers and gate-model quantum computers. Our mission is to unlock the power of quantum computing today to benefit business and society. We do this by
              delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. D-Wave&#8217;s
              technology is being used by some of the world&#8217;s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO,
              Lockheed Martin, Forschungszentrum J&#252;lich, University of Southern California, and Los Alamos National Laboratory.</div>
            <div><br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-weight: bold;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div class="BRPFPageHeader" style="width: 100%;">
                <div style="text-align: right;">Exhibit 99.1</div>
              </div>
            </div>
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Forward Looking Statements</div>
            <div><br>
            </div>
            <div style="color: rgb(0, 0, 0);">This press release includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section 21E of the
              Exchange Act. These statements express a belief, expectation or intention and are generally accompanied by words that convey projected future events or outcomes. For example, statements regarding the Company&#8217;s intention to consider
              alternatives to cure the NYSE continued listing requirement deficiency are forward-looking statements. We have based these forward-looking statements on our current expectations and assumptions and analyses made by us in light of our
              experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate under the circumstances. However, whether actual results and developments will
              conform with our expectations and predictions is subject to a number of risks and uncertainties, many of which are beyond our control, including the Company&#8217;s ability to regain compliance with the continued listing standards of the NYSE
              within the applicable cure period, the Company&#8217;s ability to continue to comply with applicable listing standards of the NYSE and the other important factors set forth under the caption &#8220;Risk Factors&#8221; in the Company&#8217;s Registration Statement on
              Form S-1 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 13, 2023, and the Company&#8217;s other reports filed with the SEC. All of the forward-looking statements made in this press release are qualified by these
              cautionary statements. The actual results or developments anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on our Company or our business or operations. Such
              statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. You should not place undue reliance on forward-looking statements, which
              speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable
              securities laws.</div>
            <div><br>
            </div>
            <div>
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Contacts</div>
            </div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">Investor Contact:</div>
            <div style="text-align: justify; color: rgb(0, 0, 0);">Kevin Hunt</div>
            <div style="text-align: justify; color: rgb(0, 0, 0);"><u>ir@dwavesys.com</u></div>
            <div><br>
            </div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">Media Contact:</div>
            <div style="color: rgb(0, 0, 0);">Michelle Maggs</div>
            <div style="color: rgb(0, 0, 0);"><u>media@dwavesys.com</u></div>
            <div><br>
            </div>
            <div><br>
            </div>
            <div>
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
          </div>
        </div>
          </div>
    </div>
    <div> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  U 5H# 2(  A$! Q$!_\0
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MF1CZ #)KQG_AH[PY_P! O4__ !S_ !KJ_CWK']C?"O6F1MDUT@LX_?S#@_\
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MM%0ZC:O]IMO=AU7\03^.*^,[6XO]"U9)[=Y;+4+63@CY'C84 ?HE4;N$4LY
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M]O''_/\ 6W_?D4 ?9F!Z4M?&7_"]O''_ #_6W_?D4?\ "]O''_/];?\ ?D4
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AVG_!+PAI%]9ZG:1WWVBUE6XCWSY&Y#O';U%>K444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
